Skip to main content
. 2021 May 26;12:681223. doi: 10.3389/fphar.2021.681223

FIGURE 2.

FIGURE 2

Lidocaine reduces the proliferation of ovarian and breast cancer cells in vitro. (A–H) SKOV-3 and T47D cells were treated with lidocaine (3 mM). (A,B) The cell viability was detected by MTT assays. (C,D) The cell proliferation was measured by colony formation assays. (E,F) The apoptosis was analyzed by flow cytometry. (G) The expression of Bcl-2, Bax, caspase3, and cleaved-caspase3 was detected by Western blot. The results were quantified using ImageJ software. (H) The expression of RIPK3 was measured by Western blot. The results were quantified using ImageJ software. mean ± SD, **p < 0.01. The experiments were performed independently three times.